KYMR Kymera Therapeutics, Inc.

NASDAQ
$121.05

Kymera Therapeutics, Inc. (KYMR) Institutional Ownership

What the institutions did with KYMR last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
294
filed a 13F this quarter
Managers holding
270
+19 on the quarter
Buyers
140
43 opened new
Sellers
107
24 sold out entirely
Buyer share
56.7%
of managers who traded it
Breadth
+13.4
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
FMR LLC 12.3M 12.7%
BAKER BROS. ADVISORS LP 8.7M 8.9%
Avoro Capital Advisors LLC 7.5M 7.7%
PRICE T ROWE ASSOCIATES INC /MD/ 7.1M 7.3%
T. Rowe Price Investment Management, Inc. 6.3M 6.5%
BlackRock, Inc. 5.5M 5.7%
BVF INC/IL 3.9M 4.0%
WELLINGTON MANAGEMENT GROUP LLP 3.7M 3.8%
VANGUARD PORTFOLIO MANAGEMENT LLC 3.0M 3.1%
Siren, L.L.C. 2.9M 3.0%
VANGUARD CAPITAL MANAGEMENT LLC 2.9M 3.0%
Atlas Venture Life Science Advisors, LLC 2.8M 2.9%
STATE STREET CORP 2.7M 2.8%
GEODE CAPITAL MANAGEMENT, LLC 1.8M 1.9%
Capital Research Global Investors 1.4M 1.4%
GOLDMAN SACHS GROUP INC 1.2M 1.2%
UBS Group AG 1.0M 1.0%
ALLIANCEBERNSTEIN L.P. 981.5K 1.0%
Driehaus Capital Management LLC 919.2K 0.9%
Merck & Co., Inc. 772.2K 0.8%
NORGES BANK 757.2K 0.8%
FEDERATED HERMES, INC. 749.4K 0.8%
DIMENSIONAL FUND ADVISORS LP 745.2K 0.8%
FRONTIER CAPITAL MANAGEMENT CO LLC 740.9K 0.8%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 736.9K 0.8%

Largest changes

Manager Action Previous Current Change
Atlas Venture Life Science Advisors, LLC Reduced 4.6M 2.8M -1.7M
BVF INC/IL Reduced 5.5M 3.9M -1.6M
PRICE T ROWE ASSOCIATES INC /MD/ Increased 6.1M 7.1M +1.1M
T. Rowe Price Investment Management, Inc. Increased 5.5M 6.3M +792.3K
FMR LLC Increased 11.7M 12.3M +649.3K
DEERFIELD MANAGEMENT COMPANY, L.P. Sold Out 561.2K 0 -561.2K
Commodore Capital LP Reduced 750.0K 250.0K -500.0K
BlackRock, Inc. Increased 5.1M 5.5M +477.3K
STATE STREET CORP Increased 2.4M 2.7M +347.5K
Clearbridge Investments, LLC New 0 347.2K +347.2K
GOLDMAN SACHS GROUP INC Increased 888.4K 1.2M +298.9K
Woodline Partners LP Increased 203.6K 500.9K +297.3K
Capital Research Global Investors Reduced 1.7M 1.4M -284.4K
Siren, L.L.C. Reduced 3.2M 2.9M -251.0K
WELLINGTON MANAGEMENT GROUP LLP Reduced 3.9M 3.7M -214.7K
FEDERATED HERMES, INC. Increased 536.7K 749.4K +212.7K
Holocene Advisors, LP Reduced 836.8K 636.6K -200.2K
GEODE CAPITAL MANAGEMENT, LLC Increased 1.6M 1.8M +171.0K
MARSHALL WACE, LLP New 0 167.5K +167.5K
FRANKLIN RESOURCES INC Increased 361.8K 515.1K +153.3K
DIMENSIONAL FUND ADVISORS LP Increased 592.9K 745.2K +152.3K
First Turn Management, LLC Reduced 254.7K 102.5K -152.1K
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduced 875.9K 736.9K -139.0K
Freestone Grove Partners LP Reduced 156.8K 21.2K -135.6K
RAYMOND JAMES FINANCIAL INC New 0 135.6K +135.6K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.